BMO Capital analyst Daniel Salmon maintains IAC/InterActiveCorp (NASDAQ:IAC) with a Outperform and lowers the price target from $195 to $173.
Co-Diagnostics’ Joint Venture, CoSara, Receives Clearance From Indian Regulators For ABC Multiplex Test
Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics